Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

FAQ: Everything to Know About Excipients in the Digital Era

ByChristopher Cole

November 20th 2025

Audits, Inspections, and CDMOs

BySusan J. Schniepp,Siegfried Schmitt,Anita Michael,Susan Haigney

November 20th 2025

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

ByFeliza Mirasol,Patrick Lavery

November 19th 2025

Concept image of the six most common questions | Image Credit: © RTimages - stock.adobe.com

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

ByChristopher Cole

November 19th 2025

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

ByFeliza Mirasol,Patrick Lavery

November 18th 2025

February 2005

Articles in this issue

Newsletter

Related Content

FAQ: Everything to Know About Excipients in the Digital Era

Audits, Inspections, and CDMOs

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

Trending on Pharmaceutical Technology

New Targets for Clinical Trials in the European Union

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care